Emerging Roles of DDB2 in Cancer

Pauline Gilson1, Guillaume Drouot2, Andréa Witz3

  • 1Institut de Cancérologie de Lorraine, Service de Biopathologie, Université de Lorraine, CNRS UMR 7039 CRAN, 54519 Vandœuvre-lès-Nancy CEDEX, France. p.gilson@nancy.unicancer.fr.

Insights

Damage-specific DNA-binding protein 2 (DDB2) is crucial for DNA repair and impacts cancer development. This review explores DDB2's roles in tumor progression and its clinical relevance.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Damage-specific DNA-binding protein 2 (DDB2) is a key factor in DNA repair pathways, particularly global genomic nucleotide excision repair (GG-NER).
  • Beyond DNA repair, DDB2 influences critical cellular processes including chromatin remodeling, gene transcription, cell cycle control, and protein degradation.
  • Emerging evidence highlights DDB2's significant involvement in the development and progression of various cancers.

Purpose of the Study:

  • To review the current scientific understanding of DDB2's biological effects on tumor development.
  • To elucidate the molecular mechanisms by which DDB2 influences carcinogenesis.
  • To provide insights into the clinical implications of DDB2 activity in cancer.

Main Methods:

  • Literature review of existing studies on DDB2.
  • Analysis of molecular mechanisms underlying DDB2's role in cancer.
  • Synthesis of clinical data related to DDB2 in various cancers.

Main Results:

  • DDB2 activity is implicated in multiple stages of carcinogenesis, including cancer cell proliferation, survival, and metastasis.
  • DDB2 influences epithelial to mesenchymal transition, migration, invasion, angiogenesis, and cancer stem cell formation.
  • The molecular pathways connecting DDB2 function to tumor progression are complex and multifaceted.

Conclusions:

  • DDB2 plays a multifaceted role in cancer development, acting as a significant contributor to tumor progression.
  • Understanding DDB2's molecular functions is crucial for developing targeted cancer therapies.
  • Further research into DDB2's clinical consequences may lead to novel diagnostic and therapeutic strategies in oncology.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.6K